Professor of Medicine, Profs. Malfertheiner, Leja, Dr Schulz, Richen Hongkong Sight and other speakers are billed to speak from August 16-17, 2024, at the first-ever International Conference of the African Helicobacter & Microbiota Study Group (AHMSG).
The two-day International Conference is free for students and Resident doctors will be held at the President Hotel, Alexander Road, Bantry Bay, Cape Town, South Africa.
Peter Malfertheiner is the conference’s keynote speaker and chairman of the Department of Gastroenterology, Hepatology and Infectious Diseases at Otto v. Guericke University of Magdeburg in Germany since 1995. He also the founding member of the European Helicobacter & Microbiota Study Group (EHMSG) who focuses his research on Helicobacter pylori-associated clinical manifestations, gastric cancer and pancreatic diseases.
Prof. Leja is a Professor of Medicine and Vice-dean of the Faculty of Medicine, University of Latvia. He is a Gastroenterologist at Digestive Diseases Centre GASTRO. His research interests are Helicobacter pylori, gastritis and gastric cancer, gastrointestinal cancer prevention, celiac disease, and diagnostic methods in gastroenterology and oncology.
Dr. Schulz was Director of Medical Department 2, LMU-Hospital Munich, Germany. His research interests revolve around Helicobacter pylori, Gastrointestinal microbiome beyond Helicobacter pylori, gastrointestinal microbiome & gastrointestinal diseases including IBS, Gastrointestinal microbiome & autonomy in the elderly—effect of the microbial community on health & diseases and Helicobacter cancer.
Richen, the company Richen Sight Hong Kong, was founded in July 2002 and has more than ten years of history. Over the years, Richen developed its outstanding enterprise culture as Honesty, Innovation, Rapidity, Learning, Honour, Harmony, Competition and Customer to contribute to its success in business, inspiring every Richener to help win a high market reputation. To guarantee sustainable improvement in services and quality, Richen has established the system management according to ISO 9001 and ISO 13485, authenticated by China Medical Device CMD in China and the Technical Inspection Association (TUV) in Germany.
In addition, a number of the Richen products have been regulated, and they possess the Conformite European (CE) safety certificate.
The African Helicobacter and Microbiota Study Group (AHMSG), founded in 2022, aimed at establishing appropriate diagnostic methods and guidelines for the treatment and management of Helicobacter pylori (an ulcer-causing pathogen) infections in Africa similar to the Maastricht VI Florence Consensus Report of the European Helicobacter & Microbiota Study Group and to connect with EHMSG for advice as a parent body.
Professor Stella Smith FAS, who has been the founding President of the AHMSG since 2022, brought about 16 members from 10 African countries as Board members; the countries are listed as Nigeria, South Africa, Zambia, Kenya, Cameroon, Tanzania, Democratic Republic of Congo, Namibia, Senegal and Morocco.
The Group also comprises over 90 ordinary members. The Group has been involved in formulating recommendations for the appropriate diagnosis and treatment of H. pylori (an ulcer-causing pathogen). Prof. Smith FAS will be handing over to Prof. Mashiko from South Africa, who will pilot the affairs of the AHMSG for the next two years.